BioSpace News Archive

Mainz Biomed NV announced the establishment of commercial partnerships for ColoAlert with Marylebone Laboratory and Instituto de Microecologia, two leading independent laboratories covering England and Spain.

Taiwan-based Formosa Pharmaceuticals announced that the company has entered into a collaboration agreement with Eyenovia, Inc. for the development of novel ophthalmic therapeutics.

Gamma Biosciences announced that it has entered into an agreement with Swedish life sciences company Biotage AB, whereby Biotage will acquire Gamma’s operating company, Astrea Bioseparations, in exchange for newly issued shares in Biotage, creating a global chromatography leader with an attractive mix of products and services across multiple end-markets globally.

Midatech Pharma PLC, a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines, announces the closing of the Private Placement of 10,344,822 Units initially at an issue price of US$0.58 per Unit.

Continued strong recruitment in the dose escalation part of the fostrox study.

Immuron Limited invites investors to join a live webcast hosted by Steven Lydeamore, CEO of Immuron Limited.

Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, announced the limited commercial release of Kurin Jet™, a significant technological advance over Kurin’s own market-leading Kurin Lock®.

NanoViricides, Inc., reports that it has filed its Quarterly Report on Form 10-Q for the fiscal first quarter ending December 31, 2022 with the Securities and Exchange Commission on Tuesday, February 14, 2023.

Editas Medicine, Inc., a clinical stage genome editing company, announced that it will host a conference call and webcast on Wednesday, February 22, 2023, at 8:00 a.m. ET to discuss results for the fourth quarter and full year of 2022 and to provide a corporate update.

Waters Corporation (NYSE:WAT) today announced it has entered into an agreement to acquire Wyatt Technology, a pioneer in innovative light scattering and field-flow fractionation instruments, software, accessories, and services, for $1.36 billion in cash, subject to certain adjustments.